Neurofibrillary Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Neurochemistry

• Publication date

  1999-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1471-4159.1999.0721243.xPMID 10037497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement

  2004cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998influential reference
• Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation

  1998cited by this paper
• Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

  1998cited by this paper
• Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17.

  1997influential reference
• Two‐Dimensional Characterization of Paired Helical Filament‐Tau from Alzheimer's Disease: Demonstration of an Additional 74‐kDa Component and Age‐Related Biochemical Modifications

  1997influential reference
• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• Modeling the relation between neurofibrillary tangles and intellectual status.

  1997cited by this paper
• Accuracy of the Clinical Diagnosis of Corticobasal Degeneration

  1997cited by this paper
• Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.

  1997cited by this paper
• Normal and pathological Tau proteins as factors for microtubule assembly.

  1997influential reference
• Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.

  1997cited by this paper
• 6 Pathological Tau proteins are biochemical markers that differentiate several types of neurofibrillary degeneration

  1996influential reference
• AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease.

  1996cited by this paper
• Neurofibrillary Tangles in Progressive Supranuclear Palsy Contain the Same Tau Epitopes Identified in Alzheimer's Disease PHFtau

  1996cited by this paper
• Clinical and pathological characteristics of primary progressive aphasia and frontal dementia.

  1996cited by this paper
• Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick’s disease

  1996influential reference
• Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

  1995cited by this paper
• Molecular dissection of the paired helical filament.

  1995influential reference
• Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau.

  1995influential reference
• Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau (*)

  1995cited by this paper
• Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease

  1994cited by this paper
• Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.

  1992cited by this paper
• Abnormal Tau proteins in progressive supranuclear palsy

  1991cited by this paper
• NEUROFIBRILLARY TANGLES IN PROGRESSIVE SUPRANUCLEAR PALSY: ELECTRON MICROSCOPIC OBSERVATIONS

  1974cited by this paper

• Cortical hyperexcitability in corticobasal syndrome as revealed by giant somatosensory evoked potentials.

  2025cites this paper
• Tau protein aggregation: A therapeutic target for neurodegenerative diseases.

  2025cites this paper
• The Current Role of Tau PET Imaging in Neurodegeneration.

  2025cites this paper
• A novel pThr217 tau monoclonal antibody reveals neuropathological heterogeneity in tauopathies

  2025cites this paper
• A human Tau expressing zebrafish model of progressive supranuclear palsy identifies Brd4 as a regulator of microglial synaptic elimination

  2024cites this paper
• Mosaic midbrain organoids: a new tool to study Progressive Supranuclear Palsy and advancing clinical neurology research

  2024cites this paper
• Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease

  2024cites this paper
• Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies

  2024cites this paper
• Alzheimer's disease and related tauopathies: disorders of disrupted neuronal identity.

  2023cites this paper
• Disease-Associated Mutations in Tau Encode for Changes in Aggregate Structure Conformation

  2023cites this paper
• SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease

  2023cites this paper
• In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers

  2023cites this paper
• Polymerization of recombinant tau core fragments in vitro and seeding studies in cultured cells

  2023cites this paper
• Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy

  2023cites this paper
• Generation of 17q21.31 duplication iPSC-derived neurons as a model for primary tauopathies.

  2022cites this paper
• Genetic Factors That Could Affect Concussion Risk in Elite Rugby

  2021cites this paper
• A Systematic Review of Apathy and Depression in Progressive Supranuclear Palsy

  2021cites this paper
• Tau Protein and Frontotemporal Dementias.

  2021cites this paper
• Cryo-EM structures of τ filaments from human brain

  2021cites this paper
• Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies.

  2021cites this paper
• Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains.

  2021cites this paper
• Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer’s disease

  2021cites this paper
• Tau in the gut, does it really matter?

  2021cites this paper
• Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration

  2021cites this paper
• Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies

  2021cites this paper
• Nanotechnology: An Emerging Field in Protein Aggregation and Cancer Therapeutics

  2021cites this paper
• Mass spectrometry analysis of tau and amyloid‐beta in iPSC‐derived models of Alzheimer’s disease and dementia

  2021cites this paper
• Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains.

  2020cites this paper
• Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau

  2020cites this paper
• The coevolution of atomic resolution and whole-brain imaging for tau neurofibrillary tangles.

  2020cites this paper
• Progressive supranuclear palsy: Advances in diagnosis and management.

  2020cites this paper
• Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

  2020cites this paper
• Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects

  2020cites this paper
• Novel tau filament fold in corticobasal degeneration

  2020cites this paper
• Tau proteinopathies and the prion concept.

  2020cites this paper
• Frontrunner in Translation: Progressive Supranuclear Palsy

  2019cites this paper
• Tau and Axonal Transport Misregulation in Tauopathies.

  2019cites this paper
• Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein.

  2019cites this paper
• Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors

  2019cites this paper
• New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease.

  2019cites this paper
• Novel tau filament fold in corticobasal degeneration, a four-repeat tauopathy

  2019cites this paper
• Is it Useful to Classify Progressive Supranuclear Palsy and Corticobasal Degeneration as Different Disorders? No

  2018cites this paper
• Mechanistic and Structural Origins of the Asymmetric Barrier to Prion-like Cross-Seeding between Tau-3R and Tau-4R.

  2018cites this paper
• Implication des systèmes de dégradation cellulaire, de la protéine VCP et de nouvelles molécules sur le métabolisme de l’APP : aspects fondamentaux et appliqués à la maladie d’Alzheimer

  2018cites this paper
• Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies

  2018cites this paper
• Caractérisation d'anticorps à domaine unique dirigés contre la protéine Tau

  2018cites this paper
• Prion-like Spreading in Tauopathies.

  2018cites this paper
• Improving the Detection Limit of Tau Aggregates for Use with Biological Samples

  2018cites this paper
• Rôle de la dérégulation neuronale de la protéine kinase activée par l’AMP (AMPK) dans la pathologie tau, l’intégrité des synapses et le métabolisme énergétique : relevance pour la maladie d’Alzheimer

  2018cites this paper
• Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies

  2017influential citation
• Alternative splicing in aging and age-related diseases

  2017cites this paper
• Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture

  2017cites this paper
• Exposure of the Amino Terminus of Tau Is a Pathological Event in Multiple Tauopathies.

  2017cites this paper
• Molecular mechanisms underlying the development of tau pathology caused by tau fragmentation

  2017cites this paper
• Pick's disease with neuronal four‐repeat tau accumulation in the basal ganglia, brain stem nuclei and cerebellum

  2017cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1182 Altered proteins in the aging brain

  2016cites this paper
• UPDATE Is Huntington’s disease a tauopathy?

  2016cites this paper
• Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

  2016cites this paper
• The Abundance of Nonphosphorylated Tau in Mouse and Human Tauopathy Brains Revealed by the Use of Phos-Tag Method.

  2016cites this paper
• Apathy and impulsivity in frontotemporal lobar degeneration syndromes

  2016cites this paper
• Is Huntington's disease a tauopathy?

  2016cites this paper
• Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.

  2016cites this paper
• Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases

  2016cites this paper
• Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.

  2016influential citation
• Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau

  2015influential citation
• De la cellule au primate, propagation physiopathologique de la protéine Tau

  2015influential citation
• Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.

  2015cites this paper
• Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations

  2015cites this paper
• Tau Protein: Biology and Pathobiology

  2015cites this paper
• Progressive Supranuclear Palsy

  2015cites this paper
• Polymorphism of Tau Fibrils

  2014cites this paper
• Clinico‐Pathological Correlation in Progressive Ataxia and Palatal Tremor: A Novel Tauopathy

  2014cites this paper
• Proteins Recruited to Exosomes by Tau Overexpression Implicate Novel Cellular Mechanisms Linking Tau Secretion with Alzheimer's Disease

  2014cites this paper
• Increased protein aggregation in Zucker Diabetic Fatty rat brain: identification of key mechanistic targets and the therapeutic application of hydrogen sulfide

  2014cites this paper
• Characterization of tau oligomeric seeds in progressive supranuclear palsy

  2014cites this paper
• Brain Injury in the Context of Tauopathies

  2014cites this paper
• Therapeutic and diagnostic challenges for frontotemporal dementia

  2014cites this paper
• Inflammatory pathology in neurodegenerative dementias

  2014cites this paper
• Targeting mRNA for Alzheimer's and Related Dementias

  2014cites this paper
• Hypoxia alters expression of Zebrafish Microtubule-associated protein Tau (mapta, maptb) gene transcripts

  2014cites this paper
• Differentiation of Progressive Supranuclear Palsy: clinical, imaging and laboratory tools

  2013cites this paper
• The Importance of Tau Phosphorylation for Neurodegenerative Diseases

  2013cites this paper
• Frontotemporal dementia–amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1–q12.2: genetic, clinical and neuropathological analysis

  2013cites this paper
• [Differential diagnosis of corticobasal syndrome (CBS) and its biomarkers].

  2013cites this paper
• Basal Ganglia Disorders

  2013cites this paper
• Untangling the role of tau in Alzheimer’s disease: A unifying hypothesis

  2013cites this paper
• Specific Profile of Tau Isoforms in Argyrophylic Grain Disease

  2013cites this paper
• Modifications of the tau protein and their varied effects on aggregation and function

  2013cites this paper
• Novel techniques for analyzing the expression of two isoform-groups derived from the gene encoding the microtubule-associated protein tau and a tertiary structure of the gene products

  2013influential citation
• Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in Aggresomes*

  2012cites this paper
• Cytoskeleton and Human Disease

  2012cites this paper
• Is tau ready for admission to the prion club?

  2012cites this paper
• Tau Overexpression Results in Its Secretion via Membrane Vesicles

  2012cites this paper
• The Microtubule-Dissociating Tau in Neurological Disorders

  2012cites this paper
• MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies

  2012cites this paper
• On the 'classification' of neurodegenerative disorders: discrete entities, overlap or continuum?

  2012cites this paper
• The Biology and Pathobiology of Tau Protein

  2012cites this paper
• MODEL HIRANO BODIES DIFFERENTIALLY MODULATE CELL DEATH INDUCED BY TAU AND THE AMYLOID PRECURSOR PROTEIN INTRACELLULAR DOMAIN by WILLIAM EUGENE SPEARS

  2012cites this paper
• Density and spatial pattern of β-amyloid (Aβ) deposits in corticobasal degeneration.

  2011cites this paper
• Progressive supranuclear palsy and corticobasal degeneration.

  2011cites this paper